It is worth noting that these results reflect the current focus of AD research, which is shifting away from the amyloid hypothesis (Morris et al., 2014) and toward Tau (Josse and Husson, 2016) and brain metabolism (Neth and Craft, 2017) as primary pathogenic events of interest. This evidence concerns the gene MAPT and Alzheimer disease.